| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
X4 Pharmaceuticals, Inc (XFOR) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. XFOR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 2.33M | $10.17M | - | |
| Pres | 2.33M | $10.17M | - | |
| CFO | 1.55M | $6.78M | - | |
| Other | 25.3K | $110.6K | - | |
| Other | 9.5K | $41.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2024 | Mostafa Adam S.75 | Chief Financial Officer | Sell | 230,645 | $0.55 | $126,900.88 | -100% | +40.0% | -78.3% | |
| Oct 7, 2024 | Baldry Mark56 | Chief Commercial Officer | Sell | 11,127 | $0.58 | $6,505.96 | -18.7% | +40.0% | -78.3% | |
| Oct 7, 2024 | Ragan Paula77 | President And CEO | Sell | 239,436 | $0.55 | $131,522.19 | -18.5% | +40.0% | -78.3% | |
| Oct 7, 2024 | Dibiase Mary71 | Chief Operating Officer | Sell | 67,695 | $0.57 | $38,328.91 | -13.0% | +40.0% | -78.3% | |
| Oct 7, 2024 | Taveras Arthur63 | Chief Scientific Officer | Sell | 76,920 | $0.56 | $43,305.96 | -16.5% | +40.0% | -78.3% | |
| Sep 9, 2024 | Dibiase Mary71 | Chief Operating Officer | Sell | 2,642 | $0.66 | $1,737.64 | -0.9% | -20.6% | -83.6% | |
| Mar 11, 2024 | Taveras Arthur63 | Chief Scientific Officer | Sell | 14,235 | $0.88 | $12,552.42 | -5.7% | +13.9% | -65.1% | |
| Mar 11, 2024 | Ragan Paula77 | President And CEO | Sell | 49,678 | $0.88 | $43,855.74 | -6.1% | +13.9% | -65.1% | |
| Mar 11, 2024 | Mostafa Adam S.75 | Chief Financial Officer | Sell | 52,500 | $0.88 | $46,347.00 | -100% | +13.9% | -65.1% | |
| Mar 11, 2024 | Dibiase Mary71 | Chief Operating Officer | Sell | 15,409 | $0.88 | $13,590.74 | -5.0% | +13.9% | -65.1% |